0
0
DUBLIN, March 6, 2020 /PRNewswire/ — The “Clinical Trial Supplies Market by Products & Services (Manufacturing, Packaging, Logistics, Distribution, Storage), Phases ( l, ll, lll, lV), Drug Type (Small Molecule, Biologics),Therapeutic Areas (Oncology, Blood Disorders) – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.
The global clinical trial supplies market is projected to reach USD 2.5 billion by 2025 from USD 1.71 billion in 2020, at a CAGR of 7.8% during the forecast period of 2020 to 2025.
Prominent players operating in the global clinical trial supplies market include Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US), Sharp Packaging Services (US), Biocair (UK), O&M Movianto (US), KLIFO A/S (Denmark), and Thermo Fisher Scientific, Inc. (US).
Increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the globalization of clinical trials & harmonization of regulations are driving the overall growth of the clinical trial supplies market
The growth of this market is majorly driven by the increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the globalization of clinical trials & harmonization of regulations. However, the increasing cost of drug development and clinical trials is expected to restrain the growth of this market during the forecast period.
Logistics services segment to account for the largest share of the clinical trial supplies market in 2020
Based on service, the clinical trial supplies market is segmented into logistics; distribution, storage, and retention; packaging, labeling, and blinding; manufacturing; comparator sourcing; and solutions. The logistics services segment is expected to account for the largest share of the clinical trial supplies market during the forecast period. This can primarily be attributed to the globalization of clinical trials and the increasing number of trials involving temperature-sensitive products.
Oncology segment to account for the largest share of the clinical trial supplies market, by therapeutic area, in 2020
Based on the therapeutic area, the clinical trial supplies market is segmented into oncology, neurological and mental disorders, infectious and immune system diseases, digestive system diseases, blood disorders, and other therapeutic areas. The oncology segment is expected to account for the largest share of the market in 2020 and is estimated to register the highest growth during the forecast period majorly due to the high and growing number of research studies on cancer therapeutics and a large number of companies focusing on bringing innovative cancer drugs to the market.
North America will continue to dominate the clinical trial supplies market during the forecast period
In 2020, North America is estimated to be the largest regional market for clinical trial supplies, followed by Europe. The presence of well-established CROs and the high and growing investments in drug discovery and development by pharmaceutical and biopharmaceutical companies in North America are the major factors responsible for the large share of this region in the global market.
However, the Asia-Pacific market is estimated to grow at the highest CAGR during the forecast period majorly due to the growing number of CROs in the region and the presence of less-stringent regulations for clinical trials and patient recruitment in emerging Asia-Pacific countries.
Key Topics Covered
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Market Overview
4.2 North American Market, By Drug Type & Country, 2020
4.3 Geographical Snapshot of the Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing R&D Expenditure in the Pharmaceutical & Biopharmaceutical Industry
5.2.1.2 Globalization of Clinical Trials and Harmonization of Regulations Resulting in the Outsourcing of Clinical Trial Activities
5.2.2 Restraints
5.2.2.1 Increasing Cost of Drug Development and Clinical Trials
5.2.3 Opportunities
5.2.3.1 Patent Expirations
5.2.3.2 Emerging Markets
5.2.3.3 Growth in the Biologics Market
6 Clinical Trial Supplies Market, By Service
6.1 Introduction
6.2 Manufacturing
6.2.1 Manufacturing Services Include Full In-House CGMP Analytical Services, Bioanalytical Services, and Particle Characterization
6.3 Packaging, Labeling, and Blinding
6.3.1 Increasing Demand for Advanced Packaging to Support the Growth of This Market
6.4 Comparator Sourcing
6.4.1 Growing R&D Expenditure in the Pharmaceutical and Biopharmaceutical Industry to Drive Market Growth
6.5 Logistics
6.5.1 Globalization of Clinical Trials has Driven the Demand for Logistics Services
6.6 Distribution, Storage, and Retention
6.6.1 End-To-End Tracking of Drugs is an Important Factor in Clinical Trials
6.7 Solutions
6.7.1 Automation in Drug Discovery and Clinical Trials to Drive Market Growth
7 Clinical Trial Supplies Market, By Phase
7.1 Introduction
7.2 Phase I
7.2.1 Quality of Clinical Trial Supplies and Proper Supply and Distribution Play an Important Role in the Success of a Drug in Phase I Trials
7.3 Phase II
7.3.1 Phase II Trials are Designed to Assess the Efficacy of Drugs
7.4 Phase III
7.4.1 Involvement of a Large Number of Patients in Phase III Trials – A Major Factor Driving Market Growth
7.5 Phase IV
7.5.1 Phase IV Studies Allow Researchers to Observe the Long-Term Effects of a Particular Drug in a Considerably Larger Pool of Patients
7.6 Ba/Be Studies
7.6.1 Increasing Patent Expiration to Increase the Demand for Ba/Be Studies
8 Clinical Trial Supplies Market, By Drug Type
8.1 Introduction
8.2 Small-Molecule Drugs
8.2.1 Ease of Development of Small-Molecule Drugs to Drive Market Growth
8.3 Biologic Drugs
8.3.1 Increasing Adoption and Affordability of Biologic Drugs to Drive Market Growth
9 Clinical Trial Supplies Market, By Therapeutic Area
9.1 Introduction
9.2 Oncology
9.2.1 High and Growing Number of Research Studies on Cancer Therapeutics to Support Market Growth
9.3 Neurological and Mental Disorders
9.3.1 Increasing Number of Patients Suffering From Neurological Disorders is Driving Market Growth
9.4 Digestive System Diseases
9.4.1 Pharmaceutical Companies are Investing Significantly in R&D for the Development of Innovative Drugs for Digestive System Diseases
9.5 Infectious and Immune System Diseases
9.5.1 Emergence of New Infectious Diseases to Drive Market Growth
9.6 Blood Disorders
9.6.1 High Global Burden of Blood Disorders has Increased the Focus on Developing Effective Drugs
9.7 Other Therapeutic Areas
10 Clinical Trial Supplies Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Availability of Advanced R&D Infrastructure has Driven the Growth of the US Market
10.2.2 Canada
10.2.2.1 Preference of Pharmaceutical Companies to Conduct Clinical Trials in Canada to Support Market Growth
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Accounted for the Largest Share of the European Market
10.3.2 UK
10.3.2.1 Favorable Government Initiatives in the UK to Support Market Growth
10.3.3 France
10.3.3.1 High Number of Oncology Clinical Trials in France to Drive Market Growth
10.3.4 Italy
10.3.4.1 High Number of Clinical Trials and the Low Drug Approval Time are the Major Factors Driving Market Growth
10.3.5 Spain
10.3.5.1 Short Study Start-Up Times and Rising R&D Expenditure to Boost the Growth of the Spanish Market
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Low Cost of Clinical Trials and Large Pharmaceutical R&D Footprint in China to Drive Market Growth
10.4.2 India
10.4.2.1 Low-Cost Services and Availability of Skilled Workforce to Support Market Growth in India
10.4.3 Japan
10.4.3.1 Government Initiatives for Drug Innovation to Support Market Growth in Japan
10.4.4 Australia
10.4.4.1 Low Cost of Conducting Clinical Trials to Support Market Growth in Australia
10.4.5 Singapore
10.4.5.1 Increasing Focus of Various Companies on Singapore to Support Market Growth
10.4.6 South Korea
10.4.6.1 Government Support for Drug Innovation to Support Market Growth in South Korea
10.4.7 Rest of Asia Pacific
10.5 Rest of the World
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Other RoW Countries
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, 2018
11.3 Competitive Scenario
11.3.1 Service Launches
11.3.2 Agreements and Collaborations
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Other Developments
11.4 Competitive Leadership Mapping (2019)
11.4.1 Vendor Inclusion Criteria
11.4.2 Visionary Leaders
11.4.3 Innovators
11.4.4 Dynamic Differentiators
11.4.5 Emerging Companies
12 Company Profiles
12.1 Catalent Inc.
12.2 Almac Group
12.3 Parexel International Corporation
12.4 Thermo Fisher Scientific Inc.
12.5 PCI Services
12.6 UDG Healthcare PLC
12.7 Biocair
12.8 Bilcare Limited
12.9 O&M Movianto (Part of Owens & Minor)
12.10 KLIFO A/S
12.11 Capsugel (Part of Lonza Group)
12.12 Infosys Limited
12.13 PRA Health Sciences Inc.
12.14 Eurofins Scientific
12.15 Marken (Subsidiary of UPS)
12.16 Seveillar Clinical Trial Supplies Pvt. Ltd.
12.17 N-Side
12.18 Metrics Contract Services
12.19 SIRO Clinpharm Pvt. Ltd.
12.20 CSM-Clingen Company
For more information about this report visit https://www.researchandmarkets.com/r/sajxhr
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/global-clinical-trial-supplies-industry-report-2020-2025—oncology-expected-to-account-for-the-largest-share-of-the-market-in-2020-registering-the-highest-growth-through-2020-2025-301018898.html
SOURCE Research and Markets
To Find More Information, Go To Saubio Digital And Look Up Any Topic
